<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812442482</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812442482</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fine-Tuning Our Personalized Medicine for Otitis Media</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hurst</surname><given-names>David S.</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0194599812442482">Associate Clinical Instructor, Tufts University, Boston, Massachusetts, USA Email: <email>meear43@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>146</volume>
<issue>6</issue>
<fpage>1040</fpage>
<lpage>1040</lpage>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>The suggested algorithm presented by Dr Ruben<sup><xref ref-type="bibr" rid="bibr1-0194599812442482">1</xref></sup> on the way our physician brains should be evaluating patients with otitis media is concise and insightful. This evaluative process is applicable to both infectious otitis media (OM) and otitis media with effusion (OME). Although OME is now understood to be an allergic disease,<sup><xref ref-type="bibr" rid="bibr2-0194599812442482">2</xref>,<xref ref-type="bibr" rid="bibr3-0194599812442482">3</xref></sup> the author omits “allergy” in his list of intrinsic susceptibility factors (Table 1). Given that more than 20% of the general population is atopic, that up to 90% of patients with chronic OME have been shown to be atopic by objective testing, and that chronic OME resolves with immunotherapy<sup><xref ref-type="bibr" rid="bibr4-0194599812442482">4</xref></sup> (as published in the journal of which the author is editor-in-chief), this seems to be a significant exclusion. Allergy is a much more prevalent risk factor than all the intrinsic factors listed in his Table 1 combined. It is also more easily treated than are genetic syndromal abnormalities, maxillofacial malformations, abnormal mucociliary physiology, or immune deficiencies.</p>
<p>In consideration of “extrinsic susceptibility factors,” the presence of common allergens (dust, pollen, pets, molds) to which the patient is sensitive has been shown to be a multiplier of several of the factors listed. Atopy more than doubles the risk of OME among children exposed to tobacco smoke or in day care and quadruples the risk of an acute otitis developing into OME.<sup><xref ref-type="bibr" rid="bibr5-0194599812442482">5</xref></sup> The exponential increase of allergies these past 2 decades possibly is as much responsible for what the author identifies as the “substantial increase in the subsequent incidence and prevalence of otitis media with effusion” as is the use of antibiotics. It would therefore be helpful if allergy were included in the checklist of intrinsic factors and the presence of allergens in the environment be included among extrinsic factors cofactored into an otolaryngologist’s decision making.</p>
<sec id="section1-0194599812442482">
<title>Disclosures</title>
<p><bold>Competing interests</bold>: Dr Hurst is on the advisory committee for Merck.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812442482">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruben</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Otitis media: the application of personalized medicine</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2011</year>;<volume>145</volume>(<issue>5</issue>):<fpage>707</fpage>-<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812442482">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hurst</surname><given-names>D</given-names></name>
</person-group>. <article-title>The role of allergy in otitis media with effusion</article-title>. <source>Clin Otolaryngol</source>. <year>2011</year>;<volume>44</volume>(<issue>3</issue>):<fpage>637</fpage>-<lpage>654</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812442482">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luong</surname><given-names>A</given-names></name>
<name><surname>Roland</surname><given-names>PS</given-names></name>
</person-group>. <article-title>The link between allergic rhinitis and chronic otitis media with effusion in atopic patients</article-title>. <source>Otolaryngol Clin North Am</source>. <year>2008</year>;<volume>41</volume>(<issue>2</issue>):<fpage>311</fpage>-<lpage>323</lpage>, <fpage>vi</fpage>.</citation>
</ref>
<ref id="bibr4-0194599812442482">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hurst</surname><given-names>DS</given-names></name>
</person-group>. <article-title>Efficacy of allergy immunotherapy as a treatment for patients with chronic otitis media with effusion</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. <year>2008</year>;<volume>72</volume>(<issue>8</issue>):<fpage>1215</fpage>-<lpage>1223</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812442482">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stenstrom</surname><given-names>C</given-names></name>
<name><surname>Ingvarsson</surname><given-names>L</given-names></name>
</person-group>. <article-title>General illness and need of medical care in otitis prone children</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. <year>1994</year>;<volume>29</volume>(<issue>1</issue>):<fpage>23</fpage>-<lpage>32</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>